Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 193

Related Citations for PubMed (Select 19370693)

1.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Navaneethan SD, Pansini F, Perkovic V, Manno C, Pellegrini F, Johnson DW, Craig JC, Strippoli GF.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007784. doi: 10.1002/14651858.CD007784. Review. Update in: Cochrane Database Syst Rev. 2014;5:CD007784.

PMID:
19370693
2.

HMG CoA reductase inhibitors (statins) for kidney transplant recipients.

Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2014 Jan 28;1:CD005019. doi: 10.1002/14651858.CD005019.pub4. Review.

PMID:
24470059
3.

HMG CoA reductase inhibitors (statins) for kidney transplant recipients.

Navaneethan SD, Perkovic V, Johnson DW, Nigwekar SU, Craig JC, Strippoli GF.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD005019. doi: 10.1002/14651858.CD005019.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD005019.

PMID:
19370615
4.

HMG CoA reductase inhibitors (statins) for dialysis patients.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2013 Sep 11;9:CD004289. doi: 10.1002/14651858.CD004289.pub5. Review.

PMID:
24022428
5.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2014 May 31;5:CD007784. doi: 10.1002/14651858.CD007784.pub2. Review.

PMID:
24880031
6.

HMG CoA reductase inhibitors (statins) for dialysis patients.

Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004289. doi: 10.1002/14651858.CD004289.pub3. Review. Update in: Cochrane Database Syst Rev. 2009;(3):CD004289.

PMID:
19370598
7.

HMG CoA reductase inhibitors (statins) for dialysis patients.

Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD004289. doi: 10.1002/14651858.CD004289.pub4. Review.

PMID:
19588351
8.

HMG CoA reductase inhibitors (statins) for dialysis patients.

Navaneethan SD, Shrivastava R.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004289. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD004289.

PMID:
15495097
9.

Lipid-lowering agents for nephrotic syndrome.

Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L.

Cochrane Database Syst Rev. 2013 Dec 10;12:CD005425. doi: 10.1002/14651858.CD005425.pub2. Review.

PMID:
24327265
10.

Antioxidants for chronic kidney disease.

Jun M, Venkataraman V, Razavian M, Cooper B, Zoungas S, Ninomiya T, Webster AC, Perkovic V.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD008176. doi: 10.1002/14651858.CD008176.pub2. Review.

PMID:
23076940
11.

Statins for the primary prevention of cardiovascular disease.

Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S.

Cochrane Database Syst Rev. 2013 Jan 31;1:CD004816. doi: 10.1002/14651858.CD004816.pub5. Review.

PMID:
23440795
12.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, Black C.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007751. doi: 10.1002/14651858.CD007751.pub2. Review.

PMID:
21975774
13.

Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.

Sanders RD, Nicholson A, Lewis SR, Smith AF, Alderson P.

Cochrane Database Syst Rev. 2013 Jul 3;7:CD009971. doi: 10.1002/14651858.CD009971.pub2. Review.

PMID:
23824754
14.

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.

Palmer SC, Craig JC, Navaneethan SD, Tonelli M, Pellegrini F, Strippoli GF.

Ann Intern Med. 2012 Aug 21;157(4):263-75. doi: 10.7326/0003-4819-157-4-201208210-00007. Review.

15.

Statins for the primary prevention of cardiovascular disease.

Taylor F, Ward K, Moore TH, Burke M, Davey Smith G, Casas JP, Ebrahim S.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD004816. doi: 10.1002/14651858.CD004816.pub4. Review. Update in: Cochrane Database Syst Rev. 2013;1:CD004816.

16.

Oral adsorbents for preventing or delaying the progression of chronic kidney disease.

Wu HM, Sun HJ, Wang F, Yang M, Dong BR, Liu GJ.

Cochrane Database Syst Rev. 2014 Oct 15;10:CD007861. doi: 10.1002/14651858.CD007861.pub2. Review.

PMID:
25317905
17.

Astragalus (a traditional Chinese medicine) for treating chronic kidney disease.

Zhang HW, Lin ZX, Xu C, Leung C, Chan LS.

Cochrane Database Syst Rev. 2014 Oct 22;10:CD008369. doi: 10.1002/14651858.CD008369.pub2. Review.

PMID:
25335553
18.

Pentoxifylline for diabetic kidney disease.

Shan D, Wu HM, Yuan QY, Li J, Zhou RL, Liu GJ.

Cochrane Database Syst Rev. 2012 Feb 15;2:CD006800. doi: 10.1002/14651858.CD006800.pub2. Review.

PMID:
22336824
19.

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials.

Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC.

BMJ. 2008 Mar 22;336(7645):645-51. doi: 10.1136/bmj.39472.580984.AE. Epub 2008 Feb 25. Review. Erratum in: BMJ. 2009;339:b2951.

20.

Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease.

Strippoli GF, Navaneethan SD, Craig JC.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003967. Review.

PMID:
17054191
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk